Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20080831001141N35
IRCT20080831001141N35
Completed
Phase 3

Comparison of Two Types of Dual Ovarian Stimulation: Duostim Versus Shanghai Protocols in Patients With Poor Ovarian Reserve: A Randomized Controlled Trial

Royan Institute0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Royan Institute
Enrollment
100
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age \=35 years
  • •Antimullerian hormone (AMH) \<1\.2 ng/ml and/or antral follicular count\=5 follicles
  • •\=4 oocyte retrieved from previous ART cycle
  • •18\.5\<BMI\<30

Exclusion Criteria

  • •Endometriosis (stage III and IV)
  • •Myoma with a compression effect
  • •Uterine anomalies (Unicorn, Didelphis,etc,….)
  • •Male factor infertility with azoospermia, severe oligospermia and oligoasthenospermia, TESE/PESA

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Comparison of the difference in the number of oocytes obtained by administering the ovarian stimulation treatment as usually with administering it only once and later.
EUCTR2019-001343-44-ESInstituto Bernabeu180
Completed
Not Applicable
Mild and minimal ovarian stimulation in patients with polycystic ovarian syndrome
IRCT20080831001141N30ROYAN Institute120
Recruiting
Not Applicable
Comparison of Two Ovarian Stimulation Protocols in Polycystic Ovarian Syndrome (PCOS) Patients Undergoing IVF/ICSIPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2
IRCT20080831001141N33Royan Institute232
Completed
Phase 3
Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian RespondersAssisted Reproductive Techniques
NCT06199960Royan Institute116
Completed
Not Applicable
Comparison of controlled ovarian stimulation with clomiphen citrate HMG(Human menopausal gonadotropin) or clomiphen citrate rFSH(recombinant follicule stimulating hormon) in IUI(Intrauterine Insemination) cycles.Condition 1: Unexplained infertility. Condition 2: Male factor infertility.Female infertility, unspecifiedOligospermia NOS
IRCT201109163386N4Semnan University of Medical Sciences142